Jump to main content

yr 〜
yr

Search results 2

Pharmacokinetic parameters of gefitinib predict efficacy?and toxicity in patients with advanced non‐small cell lung cancer harboring EGFR mutations 78 2

Pharmacokinetic parameters of gefitinib predict efficacy?and toxicity in patients with advanced non‐small cell lung cancer harboring EGFR mutations 78 2
Digital博士論文障害者向け資料あり
溝口, 孝輔Springer2017-02-01Cancer Chemotherapy and Pharmacology
National Diet Library
  • Subject HeadingChemotherapy EGFR mutations Elimination half-life Gefitinib Non-small cell lung...
  • Note (General)... calculate the elimination half-life of gefitinib. ......and the median elimination half-life was 15.7 h. Th......ed to PFS. The elimination half-life was not a sign......ratio, but not elimination half-life, might be a pr......her hand, long elimination half-life was related to high-grade adv...

Pharmacokinetic parameters of gefitinib predict efficacy?and toxicity in patients with advanced non‐small cell lung cancer harboring EGFR mutations

Pharmacokinetic parameters of gefitinib predict efficacy?and toxicity in patients with advanced non‐small cell lung cancer harboring EGFR mutations
Digital博士論文
溝口, 孝輔Springer2017-02-01Cancer Chemotherapy and Pharmacology78 2p.377-382
Available onlineOther Libraries in Japan
  • Summary, etc.... calculate the elimination half-life of gefitinib. ......and the median elimination half-life was 15.7 h. Th......ed to PFS. The elimination half-life was not a sign......ratio, but not elimination half-life, might be a pr......her hand, long elimination half-life was related to high-grade adv...
  • Subject HeadingChemotherapy EGFR mutations Elimination half-life Gefitinib Non-small cell lung...

Reached to the end of result.

RSS